Kimer Med
Company Details
Status: Private
Employees: 1-10
Location:
nelson, nelson, new zealand
Type:
sample
Technology:
sample
About: Kimer Med is a New Zealand biotech company, developing a pipeline of novel, broad-spectrum antiviral drug candidates. With success against 21 different viruses so far, we're taking on the global health challenge of viral disease and future pandemic threats.
Our vision is to end the immense suffering caused by viral disease.
There are currently around 220 viruses that cause disease in humans, and only 12 of them have an approved antiviral treatment available. In other words, 95% of viral diseases lack any approved treatment, resulting in enormous unmet medical needs worldwide.
We have built and optimised a proprietary platform for the rapid development of broad-spectrum antiviral drug candidates to address these massive medical needs. Our goal is to bring to market a family of broad-spectrum antivirals to treat multiple diseases, and provide pandemic protection.
To date we have achieved efficacy against 21 different viruses, and proved the broad-spectrum capabilities of our platform. We are currently in the lead-optimisation phase and nearing phase 1 clinical trials.
In 2024, Kimer Med was recognised as one of the Fierce Biotech's 'Fierce 15 of 2024' - the best and brightest of biotech. We were also the recipients of a Merck Emerging Biotech Grant.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Kimer Med | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.